Maze Therapeutics MAZE
NASDAQ MAZE
$31.01 -0.94 (-2.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Cost of Revenue (2024 - 2026)

Updated

Maze Therapeutics (MAZE) posted Cost of Revenue of $1.79 million for Q1 2026, up 51.0% from $1.19 million a year earlier.

Analysis

Maze Therapeutics (MAZE) Cost of Revenue (2024 - 2026) Analysis & Trends

For FY2025, Maze Therapeutics' Cost of Revenue came in at $6.31 million, up 74.9% from FY2024.

  • In prior years, Maze Therapeutics' Cost of Revenue was $3.61 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Maze Therapeutics 1.72 Bn 231.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.79 Mn
Mar 31, 2025 1.19 Mn
Mar 31, 2024 1.28 Mn
API Access

Maze Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MAZE&period=max&api_key=YOUR_API_KEY